Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
September 30, 2023 -281.1%
June 30, 2023 -199.3%
March 31, 2023 -513.0%
December 31, 2022 -1.54K%
September 30, 2022 -1.58K%
June 30, 2022 -231.2%
March 31, 2022 -108.8%
December 31, 2021 -45.14%
September 30, 2021 -27.45%
June 30, 2021 -15.25%
March 31, 2021 -21.33%
December 31, 2020
September 30, 2020 -100.7%
June 30, 2020 -29.31%
March 31, 2020 -8.15%
December 31, 2019 -31.24%
September 30, 2019 -35.06%
June 30, 2019 -28.52%
March 31, 2019 -57.83%
December 31, 2018 -33.72%
September 30, 2018 -152.2%
June 30, 2018 -144.1%
March 31, 2018 -148.9%
December 31, 2017 -164.6%
September 30, 2017 -72.56%
Date Value
June 30, 2017 -18.31%
March 31, 2017 -73.86%
December 31, 2016 -42.12%
September 30, 2016 -49.14%
June 30, 2016 10.26%
March 31, 2016 0.73%
December 31, 2015 18.11%
September 30, 2015 9.82%
June 30, 2015 14.99%
March 31, 2015 15.19%
December 31, 2014 12.09%
September 30, 2014 -10.19%
June 30, 2014 14.68%
March 31, 2014 8.63%
December 31, 2013 21.89%
September 30, 2013
June 30, 2013 9.98%
March 31, 2013 36.84%
December 31, 2012 35.66%
September 30, 2012 82.58%
June 30, 2012 29.45%
March 31, 2012 24.32%
December 31, 2011 30.81%
September 30, 2011 63.51%
June 30, 2011 11.85%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 8.65%
Corcept Therapeutics, Inc. 16.45%
Johnson & Johnson 21.86%
Eli Lilly & Co. 30.88%
Lexicon Pharmaceuticals, Inc. -4.59K%

Profit Margin (Quarterly) Related Metrics